Owner Paratek Pharmaceuticals, Inc.

Inventors Levy, Stuart B.; Alekshun, Micheal N.; Podlogar, Brent; Ohemeng, Kwasi; Verma, Atul; Warchol, Tadeusz; Bhatia, Beena

Agent Watermark

Pub. Number AU-A-2011265525

Parent 2008203017

Filing date 23 December 2011

Wipo publication date 2 February 2012

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/409 (2006.01) - having four such rings, e.g. porphine derivatives, bilirubin, biliverdine

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4184 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/42 (2006.01) - Oxazoles

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/429 (2006.01) - condensed with heterocyclic ring systems

A61K 31/436 (2006.01)

A61K 31/437 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/4745 (2006.01)

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/551 - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep